BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32815857)

  • 1. Gender Differences in Outcomes of Patients With Mesothelioma.
    Alpert N; van Gerwen M; Flores R; Taioli E
    Am J Clin Oncol; 2020 Nov; 43(11):792-797. PubMed ID: 32815857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant pleural mesothelioma characteristics and outcomes: A SEER-Medicare analysis.
    Taioli E; Wolf A; Alpert N; Rosenthal D; Flores R
    J Surg Oncol; 2023 Jul; 128(1):134-141. PubMed ID: 36932968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma.
    Barsky AR; Ahern CA; Venigalla S; Verma V; Anstadt EJ; Wright CM; Ludmir EB; Berlind CG; Lindsay WD; Grover S; Cengel KA; Simone CB
    Clin Lung Cancer; 2020 Nov; 21(6):e583-e591. PubMed ID: 32611504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.
    Van Gerwen M; Alpert N; Wolf A; Ohri N; Lewis E; Rosenzweig KE; Flores R; Taioli E
    Carcinogenesis; 2019 Jun; 40(4):529-536. PubMed ID: 30649229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.
    Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Nicastri D; Rosenzweig K; Flores RM
    PLoS One; 2015; 10(12):e0145039. PubMed ID: 26660351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women with malignant pleural mesothelioma have a threefold better survival rate than men.
    Taioli E; Wolf AS; Camacho-Rivera M; Flores RM
    Ann Thorac Surg; 2014 Sep; 98(3):1020-4. PubMed ID: 24928677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
    Zhou N; Rice DC; Tsao AS; Lee PP; Haymaker CL; Corsini EM; Antonoff MB; Hofstetter WL; Rajaram R; Roth JA; Swisher SG; Vaporciyan AA; Walsh GL; Mehran RJ; Sepesi B
    Ann Thorac Surg; 2022 Jan; 113(1):200-208. PubMed ID: 33971174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and mesothelioma incidence among chrysotile asbestos miners in Balangero, Italy: A cohort study.
    Ferrante D; Mirabelli D; Silvestri S; Azzolina D; Giovannini A; Tribaudino P; Magnani C
    Am J Ind Med; 2020 Feb; 63(2):135-145. PubMed ID: 31821579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of postoperative radiotherapy in the management of malignant pleural mesothelioma : A propensity score matching of the SEER database.
    Abdel-Rahman O
    Strahlenther Onkol; 2017 Apr; 193(4):276-284. PubMed ID: 28044200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial.
    Gunatilake S; Brims FJ; Fogg C; Lawrie I; Maskell N; Forbes K; Rahman N; Morris S; Ogollah R; Gerry S; Peake M; Darlison L; Chauhan AJ
    Trials; 2014 Sep; 15():367. PubMed ID: 25238873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial.
    Trovo M; Relevant A; Polesel J; Muraro E; Barresi L; Drigo A; Baresic T; Bearz A; Fanetti G; Del Conte A; Matrone F; Reverberi C; Furlan C; Zuccon U; Fontana P; Franchin G; Minatel E
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1368-1376. PubMed ID: 33259933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of malignant pleural mesothelioma in women.
    Wolf AS; Richards WG; Tilleman TR; Chirieac L; Hurwitz S; Bueno R; Sugarbaker DJ
    Ann Thorac Surg; 2010 Sep; 90(3):949-56; discussion 956. PubMed ID: 20732523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Survival Characteristics of Sarcomatoid Subtype in Biphasic Pleural Mesothelioma.
    Harling L; Kolokotroni SM; Nair A; Smelt J; King J; Routledge T; Spicer J; Ng W; Bille A
    Ann Thorac Surg; 2019 Mar; 107(3):929-935. PubMed ID: 30389446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma.
    Asciak R; Kanellakis NI; Bibby A; Kidd A; Gerry S; Mercer R; Maskell N; Blyth KG; Fsadni P; Montefort S; Psallidas I; Rahman NM
    Chest; 2021 Nov; 160(5):1925-1933. PubMed ID: 34119515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
    Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
    Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.
    Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB
    Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant pleural mesothelioma: a population-based study of survival.
    Milano MT; Zhang H
    J Thorac Oncol; 2010 Nov; 5(11):1841-8. PubMed ID: 20975379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of pleural malignant mesothelioma in Italy: a population-based study.
    Montanaro F; Rosato R; Gangemi M; Roberti S; Ricceri F; Merler E; Gennaro V; Romanelli A; Chellini E; Pascucci C; Musti M; Nicita C; Barbieri PG; Marinaccio A; Magnani C; Mirabelli D
    Int J Cancer; 2009 Jan; 124(1):201-7. PubMed ID: 18792097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma.
    Billé A; Krug LM; Woo KM; Rusch VW; Zauderer MG
    J Thorac Oncol; 2016 Feb; 11(2):249-55. PubMed ID: 26845118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.
    Kapeles M; Gensheimer MF; Mart DA; Sottero TL; Kusano AS; Truong A; Farjah F; Laramore GE; Stelzer KJ; Patel SA
    Am J Clin Oncol; 2018 Jan; 41(1):30-35. PubMed ID: 26353120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.